Session 21 of FOPE, PharmaState Academy’s PULSE Program, advances excellence in manufacture of APIs under revised schedule M Read more
FOPE, PharmaState Academy’s 16th PULSE Session held on Oral Liquids manufacturing under Revised Schedule M Read more
BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology for biologic drugs Read more
48 Projects approved under the PLI Scheme for promotion of domestic manufacturing of KSMs/ DIs and APIs Read more
FDA discontinue rare pediatric disease designation program despite increase in RPD approvals Read more